The N-terminal extracellular segments of the chemokine receptors CCR1 and CCR3 are determinants for MIP-1alpha and eotaxin binding, respectively, but a second domain is essential for efficient receptor activation - PubMed (original) (raw)
. 1998 Aug 7;273(32):19972-6.
doi: 10.1074/jbc.273.32.19972.
Affiliations
- PMID: 9685332
- DOI: 10.1074/jbc.273.32.19972
Free article
The N-terminal extracellular segments of the chemokine receptors CCR1 and CCR3 are determinants for MIP-1alpha and eotaxin binding, respectively, but a second domain is essential for efficient receptor activation
J E Pease et al. J Biol Chem. 1998.
Free article
Abstract
CCR1 and CCR3 are seven-transmembrane domain G protein-coupled receptors specific for members of the CC chemokine subgroup of leukocyte chemoattractants. Both have been implicated in the inflammatory response, and CCR3, through its expression on eosinophils, basophils, and Th2 lymphocytes, may be especially important in allergic inflammation. CCR1 and CCR3 are 54% identical in amino acid sequence and share some ligands but not others. In particular, macrophage inflammatory protein 1alpha (MIP-1alpha) is a ligand for CCR1 but not CCR3, and eotaxin is a ligand for CCR3 but not CCR1. To map ligand selectivity determinants and to guide rational antagonist design, we analyzed CCR1:CCR3 chimeric receptors. When expressed in mouse pre-B cells, chimeras in which the N-terminal extracellular segments were switched were both able to bind both MIP-1alpha and eotaxin, but in each case, binding occurred via separate sites. Nevertheless, neither MIP-1alpha nor eotaxin were effective agonists at either chimeric receptor in either calcium flux or chemotaxis assays. These data are consistent with a multi-site model for chemokine-chemokine receptor interaction in which one or more subsites determine chemokine selectivity, but others are needed for receptor activation. Agents that bind to the N-terminal segments of CCR1 and CCR3 may be useful in blocking receptor function.
Similar articles
- Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways.
Sabroe I, Hartnell A, Jopling LA, Bel S, Ponath PD, Pease JE, Collins PD, Williams TJ. Sabroe I, et al. J Immunol. 1999 Mar 1;162(5):2946-55. J Immunol. 1999. PMID: 10072545 - A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry.
Sabroe I, Peck MJ, Van Keulen BJ, Jorritsma A, Simmons G, Clapham PR, Williams TJ, Pease JE. Sabroe I, et al. J Biol Chem. 2000 Aug 25;275(34):25985-92. doi: 10.1074/jbc.M908864199. J Biol Chem. 2000. PMID: 10854442 - Diverging binding capacities of natural LD78beta isoforms of macrophage inflammatory protein-1alpha to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils.
Struyf S, Menten P, Lenaerts JP, Put W, D'Haese A, De Clercq E, Schols D, Proost P, Van Damme J. Struyf S, et al. Eur J Immunol. 2001 Jul;31(7):2170-8. doi: 10.1002/1521-4141(200107)31:7<2170::aid-immu2170>3.0.co;2-d. Eur J Immunol. 2001. PMID: 11449371 - Macrophage inflammatory protein-1.
Menten P, Wuyts A, Van Damme J. Menten P, et al. Cytokine Growth Factor Rev. 2002 Dec;13(6):455-81. doi: 10.1016/s1359-6101(02)00045-x. Cytokine Growth Factor Rev. 2002. PMID: 12401480 Review. - Regulation of chemokine receptor expression in eosinophils.
Nagase H, Miyamasu M, Yamaguchi M, Fujisawa T, Kawasaki H, Ohta K, Yamamoto K, Morita Y, Hirai K. Nagase H, et al. Int Arch Allergy Immunol. 2001;125 Suppl 1:29-32. doi: 10.1159/000053849. Int Arch Allergy Immunol. 2001. PMID: 11408769 Review.
Cited by
- The chemokine receptor CCR8 is not a high-affinity receptor for the human chemokine CCL18.
Hussain K, Lim HD, Devkota SR, Kemp-Harper BK, Lane JR, Canals M, Pease JE, Stone MJ. Hussain K, et al. PLoS One. 2024 Sep 11;19(9):e0305312. doi: 10.1371/journal.pone.0305312. eCollection 2024. PLoS One. 2024. PMID: 39259753 Free PMC article. - Cytokine CCL9 Mediates Oncogenic KRAS-Induced Pancreatic Acinar-to-Ductal Metaplasia by Promoting Reactive Oxygen Species and Metalloproteinases.
Liou GY, Byrd CJ, Storz P, Messex JK. Liou GY, et al. Int J Mol Sci. 2024 Apr 26;25(9):4726. doi: 10.3390/ijms25094726. Int J Mol Sci. 2024. PMID: 38731942 Free PMC article. - Cholesterol Biases the Conformational Landscape of the Chemokine Receptor CCR3: A MAS SSNMR-Filtered Molecular Dynamics Study.
van Aalst EJ, McDonald CJ, Wylie BJ. van Aalst EJ, et al. J Chem Inf Model. 2023 May 22;63(10):3068-3085. doi: 10.1021/acs.jcim.2c01546. Epub 2023 May 1. J Chem Inf Model. 2023. PMID: 37127541 Free PMC article. - Structural and functional analysis of Ccr1l1, a Rodentia-restricted eosinophil-selective chemokine receptor homologue.
Kline JM, Heusinkveld LE, Taranto E, Martin CB, Tomasi AG, Hsu IJ, Cho K, Khillan JS, Murphy PM, Pontejo SM. Kline JM, et al. J Biol Chem. 2021 Jan-Jun;296:100373. doi: 10.1016/j.jbc.2021.100373. Epub 2021 Feb 3. J Biol Chem. 2021. PMID: 33548230 Free PMC article. - CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands.
Korbecki J, Grochans S, Gutowska I, Barczak K, Baranowska-Bosiacka I. Korbecki J, et al. Int J Mol Sci. 2020 Oct 15;21(20):7619. doi: 10.3390/ijms21207619. Int J Mol Sci. 2020. PMID: 33076281 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources